Investor Services
The company adheres to the highest principles of transparency and integrity management, committing to the timely, accurate, and full disclosure of information, ensuring investors are fully informed of our operational performance and development strategies.
Through continuously optimizing our corporate governance and risk management mechanisms, we are dedicated to creating long-term, stable, and attractive investment value for all shareholders.

DIVA Laboratories Stands Out from 4,500 Global Suppliers to Win Philips’ Global Supplier Innovation Award
rofessional medical display leader DIVA Laboratories, Ltd. has received dual honors in recognition of its 30 years of innovation. From a pool of more than 4,500 suppliers worldwide, DIVA was the sole recipient of Royal Philips’ Procurement Innovation Partner Health Systems award, and was also named a Top 20 Strategic Partner. These prestigious recognitions not only affirm DIVA’s outstanding innovation capabilities, but also highlight its indispensable position in the supply chains of leading Tier 1 customers worldwide.
DIVA Celebrates 30th Anniversary with Three Milestone Product Launches and New Website Debut
Industry-first 55” and 65” optical bonding surgical displays enter mass production; new QDII OTS platform to ship in July; OLED display adopted in ultrasound imaging

































